Rebecca L Shattuck-Brandt (Rebecca Shattuck-Brandt)

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 2

Top Topics

Transcription Factor

Computed Tomography

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, Christopher Andrew Johnson, Holly Crandall, Jamye F O'Neal, Rami Nayef Al-Rohil, Caroline A Nebhan, Vijaya Bharti, Kimberly B Dahlman, Gregory D Ayers, Chi Yan, Mark C Kelley, Rondi M Kauffmann, Mary Hooks, Ana Grau, Douglas B Johnson, Anna E Vilgelm, Ann Richmond
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Anna E Vilgelm, Nabil Saleh, Rebecca L Shattuck-Brandt, Kelsie Riemenschneider, Lauren Slesur, Sheau-Chiann Chen, Christopher A Johnson, Jinming Yang, Ashlyn N Blevins, Chi Yan, Douglas B Johnson, Rami Nayef Al-Rohil, Ensar Halilovic, Rondi M Kauffmann, Mark Kelley, Gregory D Ayers, Ann Richmond
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science translational medicine 11 (505) (2020)